[Therapeutic policy in cochleovestibular disorders in the presence of cerebral circulatory insufficiency].
Kunel'skaia
N L
NL
Kamchatnov
P R
PR
Gulieva
A E
AE
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001301:Audiometry, Pure-Tone; D001921:Brain / Q000098:blood supply*; D002545:Brain Ischemia / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology*; D002560:Cerebrovascular Circulation / Q000502:physiology; D015834:Cochlear Diseases / Q000188:drug therapy* / Q000453:epidemiology*; D003072:Cognition Disorders / Q000175:diagnosis / Q000453:epidemiology; D005260:Female; D006316:Hearing Loss, High-Frequency / Q000175:diagnosis / Q000453:epidemiology; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D015837:Vestibular Diseases / Q000188:drug therapy* / Q000453:epidemiology*
D000959:Antihypertensive Agents